Observed via mRNA and immunohistochemistry, in NB and patient-derived tumor xenograft (PDX)-derived cells, there is a strong positive correlation between the expression of VRK1 and that of the proliferation marker Ki67, as well as the mitotic index in the tumor. Here, VRK1 is linked to neuroblastoma.